1. Home
  2. BAFN vs PLX Comparison

BAFN vs PLX Comparison

Compare BAFN & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BayFirst Financial Corp.

BAFN

BayFirst Financial Corp.

HOLD

Current Price

$6.92

Market Cap

175.3M

Sector

Finance

ML Signal

HOLD

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$2.55

Market Cap

207.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAFN
PLX
Founded
1999
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
175.3M
207.1M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
BAFN
PLX
Price
$6.92
$2.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
102.6K
★ 836.2K
Earning Date
10-29-2026
08-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.27
Revenue
N/A
★ $52,744,000.00
Revenue This Year
N/A
$55.77
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$9.46
Revenue Growth
★ N/A
N/A
52 Week Low
$4.26
$1.65
52 Week High
$9.70
$3.19

Technical Indicators

Market Signals
Indicator
BAFN
PLX
Relative Strength Index (RSI) 51.65 42.44
Support Level $5.98 $2.21
Resistance Level $6.96 $2.75
Average True Range (ATR) 0.62 0.10
MACD 0.10 -0.02
Stochastic Oscillator 74.01 19.67

Price Performance

Historical Comparison
BAFN
PLX

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company that operates through its wholly owned subsidiary. The Company generates the majority of its revenue from interest on loans and noninterest income. The primary sources of funding for its loans are loan payments, deposits, and borrowings. It is dependent on noninterest income, which is derived from net gain on the sales of the guaranteed portion of government-guaranteed loans and service fee income. The company provides personal banking and business banking services.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: